Latest Breaking News On - Prior to concert pharmaceuticals - Page 1 : comparemela.com

BOSTON and MONTREAL, Nov. 29, 2023 /PRNewswire/ - enGene Holdings Inc. , a clinical-stage genetic medicines company whose lead program is in a pivotal study for BCG-unresponsive non-muscle.

United statesDerivatized oligochitosanJasond hansonUniversity of south carolinaGene holdings incInternational master of business administrationForbion european acquisition corporationBusiness administrationPrior to concert pharmaceuticalsExchange commissionHead of business developmentNicolaus co incGene holdingsRyan dawsChief financial officerChief executive officer